Skip to main content
. 2020 Nov 19;10:20148. doi: 10.1038/s41598-020-77186-9

Figure 2.

Figure 2

Cumulative incidence of survival after MRD positivity between the preemptive IFN-α treatment group in the present study and those who had MRD but did not receive interventions in the historical cohort: (A) relapse; (B) non-relapse mortality; (C) disease-free survival, and (D) overall survival.